![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07H 1/00 | |
C12N 1/20 | |||
C07H 19/16 | |||
C07H 19/14 | |||
C07H 19/23 | |||
A61K 38/44 | |||
C07D 307/33 | |||
A61P 31/18 |
(11) | Number of the document | 3352781 |
(13) | Kind of document | T |
(96) | European patent application number | 16849385.6 |
Date of filing the European patent application | 2016-09-19 | |
(97) | Date of publication of the European application | 2018-08-01 |
(45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/052409 |
Date | 2016-09-19 |
(87) | Number | WO 2017/053216 |
Date | 2017-03-30 |
(30) | Number | Date | Country code |
201562222304 P | 2015-09-23 | US | |
201662302452 P | 2016-03-02 | US |
(72) |
GIRIJAVALLABHAN, Vinay, M., US
MCLAUGHLIN, Mark, US
CLEATOR, Edward, GB
KONG, Jongrock, US
GIBSON, Andrew William, GB
LIEBERMAN, David, R., GB
DIEGUEZ VAZQUEZ, Alejandro, GB
KEEN, Stephen Philip, GB
WILLIAMS, Michael, J., US
MOORE, Jeffrey, C., US
MILCZEK, Erika, M., US
PENG, Feng, US
BELYK, Kevin, M., US
SONG, Zhiguo Jake, US
|
(73) |
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US |
(54) | 4`-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF |
4`-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS AND PREPARATIONS THEREOF |